# OM2, a Novel Oligomannuronate-Chromium(III) Complex, Promotes Mitochondrial Biogenesis and Lipid Metabolism in 3T3-L1 Adipocytes via the AMPK-PGC1α Pathway

**Authors:** Jiejie Hao, Cui Hao, Lijuan Zhang, Xin Liu, Xiaolin Zhou, Yunlou Dun, Haihua Li, Guangsheng Li, Xiaoliang Zhao, Yuanyuan An, Jiankang Liu, Guangli Yu

PMC · DOI: 10.1371/journal.pone.0131930 · 2015-07-15

## TL;DR

OM2, a new compound from marine alginate, boosts mitochondrial function and lipid metabolism in fat cells via the AMPK-PGC1α pathway, potentially aiding in diabetes treatment.

## Contribution

OM2 is a novel oligomannuronate-chromium(III) complex that activates the AMPK-PGC1α pathway to enhance mitochondrial biogenesis and lipid metabolism in adipocytes.

## Key findings

- OM2 activates the AMPK-PGC1α signaling pathway in 3T3-L1 adipocytes.
- OM2 increases mitochondrial biogenesis and improves mitochondrial function.
- OM2 reduces lipid accumulation through enhanced fatty acid β-oxidation and ATGL expression.

## Abstract

In our previous studies, we prepared novel oligomannuronate-chromium(III) complexes (OM2, OM4) from marine alginate, and found that these compounds sensitize insulin action better than oligomannuronate(OM), chromium, and metformin in C2C12 skeletal muscle cells. In the present study, we studied their effects on mitochondrial biogenesis, lipid metabolism, and the underlying molecular mechanisms in differentiated 3T3-L1 adipocytes.

We firstly used the pGL3-PGC1α and pGL3-ATGL promoter plasmids to compare their effects on PGC1α and ATGL transcription activities. Then mitochondrial biogenesis was quantified by transmission electron microscopy and MitoTracker staining. Mitochondrial oxygen consumption and fatty acid oxidation were measured by an oxygen biosensor system and ³H-labelled water scintillation. The mitochondrial DNA and mRNA involved in mitochondrial biogenesis and lipid oxidation were evaluated by real-time PCR. AMPK together with other protein expression levels were measured by western blotting. The inhibitor compound C and siRNA of PGC1α were used to inhibit the OM2-induced AMPK-PGC1α signaling pathway. And we found that OM2 stimulated AMPK-PGC1α pathway in the 3T3-L1 adipocytes, which were correlated with induced mitochondrial biogenesis, improved mitochondrial function, and reduced lipid accumulation by enhanced fatty acid β-oxidation and augmented ATGL protein expression.

Our data indicated that the marine oligosaccharide-derived OM2 might represent a novel class of molecules that could be useful for type 2 diabetes prevention and treatment by up-regulating AMPK-PGC1α signaling pathway.

## Linked entities

- **Genes:** PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891], PNPLA2 (patatin like domain 2, triacylglycerol lipase) [NCBI Gene 57104]
- **Proteins:** PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1), PNPLA2 (patatin like domain 2, triacylglycerol lipase)
- **Chemicals:** OM2 (PubChem CID 57345922), OM4 (PubChem CID 180287), chromium(III) (PubChem CID 27668), metformin (PubChem CID 4091), compound C (PubChem CID 11524144)
- **Diseases:** type 2 diabetes (MONDO:0005148)

## Full-text entities

- **Genes:** Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Ppargc1b (peroxisome proliferative activated receptor, gamma, coactivator 1 beta) [NCBI Gene 170826] {aka 4631412G21Rik, PGC-1beta, PGC-1beta/ERRL1, PPARGC-1-beta, Perc}, Nrf1 (nuclear respiratory factor 1) [NCBI Gene 18181] {aka D6Ertd415e}, Ocm (oncomodulin) [NCBI Gene 18261], PNPLA2 (patatin like domain 2, triacylglycerol lipase) [NCBI Gene 57104] {aka 1110001C14Rik, ATGL, FP17548, PEDF-R, TTS-2.2, TTS2}, Ppara (peroxisome proliferator activated receptor alpha) [NCBI Gene 19013] {aka 4933429D07Rik, Nr1c1, PPAR-alpha, PPARalpha, Ppar}, Cpt1a (carnitine palmitoyltransferase 1a, liver) [NCBI Gene 12894] {aka C730027G07, CPTI, Cpt1}, Sirt1 (sirtuin 1) [NCBI Gene 93759] {aka SIR2L1, Sir2, Sir2a, Sir2alpha}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, Ppargc1a (peroxisome proliferative activated receptor, gamma, coactivator 1 alpha) [NCBI Gene 19017] {aka A830037N07Rik, Gm11133, PGC-1, PPARGC-1-alpha, Pgc-1alpha, Pgc1}, Fgf21 (fibroblast growth factor 21) [NCBI Gene 56636] {aka Fgf8c}, PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1) [NCBI Gene 5564] {aka AMPK, HAMPKb}, Tfam (transcription factor A, mitochondrial) [NCBI Gene 21780] {aka Hmgts, mtTFA, tsHMG}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Pnpla2 (patatin-like phospholipase domain containing 2) [NCBI Gene 66853] {aka 0610039C21Rik, 1110001C14Rik, Atgl, TTS-2.2}
- **Diseases:** heart diseases (MESH:D006331), hyperlipidemia (MESH:D006949), toxicity (MESH:D064420), hypertension (MESH:D006973), obesity (MESH:D009765), metabolic disturbances (MESH:D024821), neurodegenerative disease (MESH:D019636), cancer (MESH:D009369), mitochondrial dysfunction (MESH:D028361), diabetes (MESH:D003920), inflammation (MESH:D007249), insulin resistance (MESH:D007333), type 2 diabetes (MESH:D003924), dyslipidemia (MESH:D050171)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Moloney murine leukemia virus (no rank) [taxon 11801]
- **Cell lines:** 3T3-L1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0123), C2C12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0188)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4503612/full.md

---
Source: https://tomesphere.com/paper/PMC4503612